CB 1 R activation in pre-synaptic terminals is mainly facilitated through retrograde signaling of endocannabinoids released from the post-synapse (Kano et al., 2009
M., Ramadan, W., Assi, G., & Khoury, N
There are also potential hormonal effects and unknown long-term risks due to limited research, especially with intravenous use, which could also strain the kidneys or liver
In addition, it also acts as an effective skin lightening agent due to its ability to inhibit melanin production.
Research to date has not documented direct pharmacological interactions between ashwagandha and semaglutide, though individual responses vary based on genetics, gut health, and dosing schedules
The main reason is the lack of scientific evidence at this current stage